Axon Partners Group is a Madrid-listed consulting firm whose revenue comes from advisory mandates in M&A, corporate finance and operational restructuring, sold mainly to mid-market and private-equity clients. Its 66% gross margin and 39.5% operating margin are unusually high for a people-driven advisory business, which points to tight cost control and pricing power rather than a scale advantage. Revenue grew 12.0% and ROE is 21.9%, so the franchise is compounding capital without much leverage, though at an 89M EUR market cap the business is small enough that a single lost client or deal slowdown would move results sharply. At 13.9x trailing and 10.8x forward earnings, the stock is priced for a modest decline in earnings, not for the 12% growth it has delivered, so the gap between the multiple and the reported growth is the first thing to test. The company is not in any index, which limits passive demand and can leave a mispricing in place for longer, but it also means liquidity is thin. A deeper look should focus on deal-flow cyclicality, client concentration, and whether the margin profile holds through a slow M&A cycle.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 23 Oct 2026, 01:53 CEST | ACCE price target | €18.90 | first publication | €17.00 |
| 22 Oct 2026, 12:04 CEST | Fair value | €22.73 | first publication | €17.00 |
| 22 Oct 2026, 12:04 CEST | Rating | Undervalued | first publication | €17.00 |
Answered from Axon Partners Group, S.A. fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| APG.MC Axon Partners Group, S.A. | €17.00 | €23 | 25% below | 13.9x | 21.9% | 95 | 73 |
| RGP Resources Connection Inc. Common Stock | $2.69 | - | - | - | -25.1% | 39 | 30 |
| AAA.PA Alan Allman Associates | €1.70 | €4 | 56% below | 42.5x | 4.7% | 25 | 32 |
| LLYC.MC Llorente & Cuenca, S.A. | €5.25 | - | - | 11.4x | 54.1% | 67 | 53 |
| DGNX Diginex Limited Ordinary Shares | $1.40 | - | - | - | -250.4% | 47 | 26 |
| FORR Forrester Research Inc. Common Stock | $12.48 | $13 | 4% below | - | -30.3% | 44 | 63 |
| ACCL Acco Group Holdings Limited Class A Ordinary Shares | $2.87 | - | - | 143.5x | 14.8% | 63 | 47 |
Where APG.MC ranks against its sector peers on each metric.